Kisqali: Side Effects & Dosing

Kisqali

Basic Prescribing Info

Contents

Ribociclib succinate

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EF02 - ribociclib ; Belongs to the class of cyclin-dependent kinase (CDK) inhibitors. Used in the treatment of cancer.

Already a member? Sign In